Developer docs
API playgroundTry for free, no card

Search company profiles

R & D Pharma

Full company profile

uuid0056qvm

Namestring
R & D Pharma
Legal namestring
R&D Pharma
Websiteurl
rd-pharma.mc
Company typeenum
Private
Founded yearint
2001
Descriptiontext

R&D Pharma is a privately held, independent pharmaceutical laboratory founded in 2001 and headquartered in the Principality of Monaco (Le Triton, 5 Rue du Gabian). The company operates in a dual regulatory capacity: as a Marketing Authorization Holder (MAH) with exploitant status under French pharmaceutical law distributing authorized medicinal products in France, and as a Manufacturer and Distributor under the EU Medical Device Regulation (EU 2017/745) with ISO 13485 Quality Management System certification. Its commercial portfolio currently consists of two authorized herbal medicinal products—Dolosoft (a traditional herbal product containing Harpagophytum dry extract for musculoskeletal conditions) and Prosoft (a well-established use herbal product for mental well-being)—both holding valid national Marketing Authorizations in France and distributed through authorized pharmaceutical wholesale channels. Pricing follows the regulatory-approved framework in France and is not publicly disclosed.

Beyond its marketed pharmaceutical business, R&D Pharma is advancing a pipeline of investigational dermatology medical devices. MDC-75 is a Class IIa device currently under regulatory review for benign superficial skin lesions including actinic keratosis, and MDC-85 is an investigational device in clinical investigation phase for superficial basal cell carcinoma (sBCC); neither is CE marked nor commercially available in the European Union. Pharmaceutical manufacturing is outsourced to GMP-compliant Contract Development and Manufacturing Organization (CDMO) partners, while R&D Pharma retains batch certification and release responsibility. The company maintains Good Clinical Practice (GCP) and Good Laboratory Practice (GLP) compliance for its clinical investigations, pharmacovigilance and post-market surveillance infrastructure, and an Investigator-Initiated Research (IIR) program for external scientific collaboration.

The go-to-market model is B2B and regulatory-driven: products reach end-users via authorized French wholesale distribution, with a recently launched WooCommerce-based direct-to-consumer e-commerce storefront currently listing placeholder test products. End customers are patients with age-related dermatological, musculoskeletal, and mental well-being conditions. The organization is described as a "human-sized" agile team with multidisciplinary expertise spanning clinical research, regulatory affairs, quality management, pharmaceutical affairs, and medical device development. Revenue, headcount, and ownership structure are not publicly disclosed; the company appears to be founder-owned or closely held with no parent, no external investors documented, and no public listing.

Short descriptiontext

R&D Pharma is a privately held Monaco-based pharmaceutical laboratory founded in 2001 that operates as a Marketing Authorization Holder in France, marketing two authorized herbal medicinal products (Dolosoft and Prosoft) while developing investigational dermatology medical devices for age-related skin conditions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMonaco, Monaco
HQ citystring
Monaco
HQ countrystring
Monaco
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical products, dermatology medical devices, herbal medicinal products, marketing authorization holder, medical device manufacturing
Industry3 codes
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAL
Dermatology Specialty Pharmaceuticals
NAICS code4 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Pharmaceutical Preparation Manufacturing325412
  • Medicinal and Botanical Manufacturing325411
  • Medical Equipment and Supplies Manufacturing3391
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
  • Surgical & Medical Instruments & Apparatus3841
Product category
Specialty Pharmaceutical Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical Product Sales
TypeOne Time License
Description

Sales of market-authorized medicinal products including Dolosoft (herbal product for musculoskeletal conditions) and Prosoft (herbal product for mental well-being). Products hold valid national Marketing Authorization in France.

rd-pharma.mc
2Medical Device Development
TypeLicensing Royalties
Description

Development of investigational dermatology medical devices (MDC-75, MDC-85) currently under regulatory review or clinical investigation. Not yet commercially available.

rd-pharma.mc
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1E-commerce test products
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

Test products listed at 100,00€ with 50% discounts bringing current price to 50,00€. These are placeholder products for platform testing, not actual company products.

rd-pharma.mc
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Dolosoft
Description

Registered traditional herbal medicinal product containing a dry extract of Harpagophytum, traditionally used in musculoskeletal conditions. Holds valid national Marketing Authorization in France.

rd-pharma.mc
+3 more records
Core offering1 text field

R&D Pharma operates as a Marketing Authorization Holder (MAH) and developer of pharmaceutical products and dermatology medical devices. Its marketed portfolio consists of two herbal medicinal products authorized in France—Dolosoft (Harpagophytum extract for musculoskeletal conditions) and Prosoft (herbal product for mental well-being). The company is also developing investigational Class IIa dermatology medical devices (MDC-75 for skin lesions including actinic keratosis, MDC-85 for superficial basal cell carcinoma) currently in regulatory review or clinical investigation. Manufacturing is outsourced to qualified GMP-compliant CDMO partners.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

R&D Pharma operates as a Marketing Authorization Holder with two authorized pharmaceutical products—Dolosoft (herbal medicinal product for musculoskeletal conditions) and Prosoft (herbal medicinal product for mental well-being)—both holding valid national Marketing Authorizations in France. In addition to its pharmaceutical portfolio, R&D Pharma is developing investigational dermatological medical devices, including MDC-75 (Class IIa device under regulatory review for skin lesions including actinic keratosis) and MDC-85 (device in clinical investigation for superficial basal cell carcinoma). The investigational devices are not yet CE marked or commercially available.

Product and service4 records
1Dolosoft
CategoryHerbal medicinal product (musculoskeletal)
2Prosoft
CategoryHerbal medicinal product (mental well-being)
3MDC-75
CategoryDermatology medical device (investigational, Class IIa)
4MDC-85
CategoryDermatology medical device (investigational, clinical phase)
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1GMP-compliant CDMO partners
Strategic tierCoreTypeOthers
Description

R&D Pharma outsources pharmaceutical manufacturing to qualified GMP-compliant Contract Development and Manufacturing Organization (CDMO) partners. The company holds appropriate GMP authorization related to batch certification and release, enabling strengthened quality control and close collaboration with manufacturing partners.

rd-pharma.mc
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

R & D Pharma

Specialty Pharmaceutical Manufacturingrd-pharma.mc

R&D Pharma is a privately held Monaco-based pharmaceutical laboratory founded in 2001 that operates as a Marketing Authorization Holder in France, marketing two authorized herbal medicinal products (Dolosoft and Prosoft) while developing investigational dermatology medical devices for age-related skin conditions.

What R & D Pharma does

R&D Pharma is a privately held, independent pharmaceutical laboratory founded in 2001 and headquartered in the Principality of Monaco (Le Triton, 5 Rue du Gabian). The company operates in a dual regulatory capacity: as a Marketing Authorization Holder (MAH) with exploitant status under French pharmaceutical law distributing authorized medicinal products in France, and as a Manufacturer and Distributor under the EU Medical Device Regulation (EU 2017/745) with ISO 13485 Quality Management System certification. Its commercial portfolio currently consists of two authorized herbal medicinal products—Dolosoft (a traditional herbal product containing Harpagophytum dry extract for musculoskeletal conditions) and Prosoft (a well-established use herbal product for mental well-being)—both holding valid national Marketing Authorizations in France and distributed through authorized pharmaceutical wholesale channels. Pricing follows the regulatory-approved framework in France and is not publicly disclosed.

Beyond its marketed pharmaceutical business, R&D Pharma is advancing a pipeline of investigational dermatology medical devices. MDC-75 is a Class IIa device currently under regulatory review for benign superficial skin lesions including actinic keratosis, and MDC-85 is an investigational device in clinical investigation phase for superficial basal cell carcinoma (sBCC); neither is CE marked nor commercially available in the European Union. Pharmaceutical manufacturing is outsourced to GMP-compliant Contract Development and Manufacturing Organization (CDMO) partners, while R&D Pharma retains batch certification and release responsibility. The company maintains Good Clinical Practice (GCP) and Good Laboratory Practice (GLP) compliance for its clinical investigations, pharmacovigilance and post-market surveillance infrastructure, and an Investigator-Initiated Research (IIR) program for external scientific collaboration.

The go-to-market model is B2B and regulatory-driven: products reach end-users via authorized French wholesale distribution, with a recently launched WooCommerce-based direct-to-consumer e-commerce storefront currently listing placeholder test products. End customers are patients with age-related dermatological, musculoskeletal, and mental well-being conditions. The organization is described as a "human-sized" agile team with multidisciplinary expertise spanning clinical research, regulatory affairs, quality management, pharmaceutical affairs, and medical device development. Revenue, headcount, and ownership structure are not publicly disclosed; the company appears to be founder-owned or closely held with no parent, no external investors documented, and no public listing.

R & D Pharma firmographics

Firmographics
Name
R & D Pharma
Legal name
R&D Pharma
Website
https://rd-pharma.mc
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Short description
R&D Pharma is a privately held Monaco-based pharmaceutical laboratory founded in 2001 that operates as a Marketing Authorization Holder in France, marketing two authorized herbal medicinal products (Dolosoft and Prosoft) while developing investigational dermatology medical devices for age-related skin conditions.
Ownership category
akta.pro rank

R & D Pharma industry classification

Industry
Product category
Specialty Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Medical Equipment and Supplies Manufacturing (3391)
SIC
Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAL
Dermatology Specialty Pharmaceuticals

Keywords

  • Pharmaceutical products
  • Dermatology medical devices
  • Herbal medicinal products
  • Marketing authorization holder
  • Medical device manufacturing

Where R & D Pharma is headquartered

Location

Headquarters

HQ city
Monaco
HQ country
Monaco
HQ region
Europe

Offices1 record

Markets served

R & D Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Pharmaceutical Product Sales: Sales of market-authorized medicinal products including Dolosoft (herbal product for musculoskeletal conditions) and Prosoft (herbal product for mental well-being). Products hold valid national Marketing Authorization in France.
  2. Medical Device Development: Development of investigational dermatology medical devices (MDC-75, MDC-85) currently under regulatory review or clinical investigation. Not yet commercially available.

Pricing tiers

ModelBillingPrice
Unit PricingOne time/ perpetual licenseE-commerce test products

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

R & D Pharma product offering

Product offering

Core offering

R&D Pharma operates as a Marketing Authorization Holder (MAH) and developer of pharmaceutical products and dermatology medical devices. Its marketed portfolio consists of two herbal medicinal products authorized in France—Dolosoft (Harpagophytum extract for musculoskeletal conditions) and Prosoft (herbal product for mental well-being). The company is also developing investigational Class IIa dermatology medical devices (MDC-75 for skin lesions including actinic keratosis, MDC-85 for superficial basal cell carcinoma) currently in regulatory review or clinical investigation. Manufacturing is outsourced to qualified GMP-compliant CDMO partners.

Product overview

R&D Pharma operates as a Marketing Authorization Holder with two authorized pharmaceutical products—Dolosoft (herbal medicinal product for musculoskeletal conditions) and Prosoft (herbal medicinal product for mental well-being)—both holding valid national Marketing Authorizations in France. In addition to its pharmaceutical portfolio, R&D Pharma is developing investigational dermatological medical devices, including MDC-75 (Class IIa device under regulatory review for skin lesions including actinic keratosis) and MDC-85 (device in clinical investigation for superficial basal cell carcinoma). The investigational devices are not yet CE marked or commercially available.

Differentiator

Problem solved

Functional benefit

Brands

  • Dolosoft: Registered traditional herbal medicinal product containing a dry extract of Harpagophytum, traditionally used in musculoskeletal conditions. Holds valid national Marketing Authorization in France.
  • Prosoft
  • MDC-75
  • MDC-85

Products and services

  • Dolosoft
  • Prosoft
  • MDC-75
  • MDC-85

Companies that use R & D Pharma

Customer profile

Segments3 records

Ideal customer profiles3 records

R & D Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

R & D Pharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • GMP-compliant CDMO partnerscoreOthersR&D Pharma outsources pharmaceutical manufacturing to qualified GMP-compliant Contract Development and Manufacturing Organization (CDMO) partners. The company holds appropriate GMP authorization related to batch certification and release, enabling strengthened quality control and close collaboration with manufacturing partners.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

R & D Pharma competitors and assessment

Company assessment

Market position

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

R & D Pharma social profiles

Digital presence

R & D Pharma compliance and trust

Trust signal

Compliance4 records

R & D Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

R & D Pharma leadership team

Management profile

Number of profiles

R & D Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

R & D Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about R & D Pharma

What does R & D Pharma do?

R&D Pharma operates as a Marketing Authorization Holder (MAH) and developer of pharmaceutical products and dermatology medical devices. Its marketed portfolio consists of two herbal medicinal products authorized in France—Dolosoft (Harpagophytum extract for musculoskeletal conditions) and Prosoft (herbal product for mental well-being). The company is also developing investigational Class IIa dermatology medical devices (MDC-75 for skin lesions including actinic keratosis, MDC-85 for superficial basal cell carcinoma) currently in regulatory review or clinical investigation. Manufacturing is outsourced to qualified GMP-compliant CDMO partners.

Is R & D Pharma a public or private company?

R & D Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was R & D Pharma founded?

R & D Pharma was founded in 2001. It employs 11 to 50 people.

Where is R & D Pharma based?

R & D Pharma is headquartered in Monaco, Monaco, in the Europe region.

How does R & D Pharma make money?

Two revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are medical Device Development.

Does R & D Pharma have an API?

No public API is recorded for R & D Pharma.

What industry is R & D Pharma in?

R & D Pharma's product category is Specialty Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 3254 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals